Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Original Research
No Relevant Pharmacokinetic Drug–Drug Interaction Between the Sodium-Glucose Co-Transporter-2 Inhibitor Empagliflozin and Lobeglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, in Healthy Subjects
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,863 | Dovepress* | 4,354+ | 557 | 4,911 | |
| PubMed Central* | 509 | 165 | 674 | ||
| Totals | 4,863 | 722 | 5,585 | ||
| *Since 28 April 2021 | |||||
View citations on PubMed Central and Google Scholar